The evolution of esophageal cancer between 2008-2013 in Mureș county Coordinator: Dr. Radu Florin Demian First author: Pál Hunor.

Slides:



Advertisements
Similar presentations
Cancer cases and deaths across the world and in the UK : October 2011 Incidence across regions There are big variations in cancer incidence across the.
Advertisements

Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer Spanish Association of Surgeons Madrid 11 November 2002 The University.
Bladder Cancer, 2006 Overview and Current Treatment Don Lamm, MD Bladder Cancer, Genitourinary Oncology, Phoenix Clinical Professor, University of Arizona,
Cancer in the Northwest Territories ( ) Highlights from the Northwest Territories Cancer Report March 2014.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
CA Esophagus – Role of Chemoirradiation WH Chan Pamela Youde Nethersole Eastern Hospital.
Oesophageal Tumours Dr M. Abrar Barakzai. Revision of basic tumour pathology Definitions Nomenclature – Benign versus Malignant – Histogenetic classification.
Lung Cancer. Lung Cancer Incidence 1950s Male/Female ratio 6:1, this is now 7:5. (decreasing male smoking rates, increasing female smoking rates). Approximately.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
Epidemiology and risk factors for esofagus cancer
Gastric Cancer Prevention Luis S. Mon, M.D., F.A.C.S. Carlos A. Perurena, M.D.
© Cancer Research UK 2007 Registered charity number Lung cancer and smoking – UK November 2009 The statistics in this presentation are based on.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Breast Cancer - UK December 2011 For more information.
Upper gastrointestinal cancers
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Gastric Cancer Epidemiology Suminori Kono, MD, PhD Professor of Preventive Medicine Kyushu Univ School of Medicine Fukuoka , Japan
CHAPTER 5 Cancer of the Esophagus Source: Burden of digestive diseases in the United States, NIH Publication No
Dr Jesme Baird The Roy Castle Lung Cancer Foundation, UK and ECPC.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Stem Cells In Clinical Practice: STELLA Experience Manolo D’Arcangelo Department of Oncology Ospedale Civile di Livorno.
Evaluation of craniocerebral traumatisms treated at the Mures County Emergency Hospital between Author: Duka Ede-Botond Supervisor: PhD Dr. Madaras.
PURE Objective Evaluate the use of cardiovascular drugs for secondary prevention across countries with differing levels of economic development Study Design.
Favoring factors of deficiency diseases in children Author: Andreea-Iulia Csiszer Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy,
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Introduction 30-40% of all cancers arise from the epithelial lining of the aerodigestive tract. 51% & 38% of cancer deaths of men and women are from lung.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Black Patients Die Earlier after Surgery for Esophageal Cancer Andrea S. Wolf, MD, MPH, Emanuela Taioli MD, PhD, Marlene Camacho-Rivera, ScD, MPH, Andrew.
OUT-OF-POCKET SPENDING ON TB AND HIV INFECTIONS IN MIDDLE- BELT, NIGERIA BY (1)UMEH, E.U., (2)UMEH, J.C. and (1)UDEH, L. (1)Dept. of Biological Sciences.
10/16/2015C.R. Apap1 Lung cancer: a preventable disease Epidemiology addresses issues related to   Heredity,  Life-style, and  Environment.
 Subhendu De, Wonsuk Yoo Institute of Public and Preventative Health (IPPH), Georgia Regents University On Summer Public Health Scholars Program (SPHSP)
Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.
YEREVAN STATE MEDICAL UNIVERSITY INCIDENCE AND STRUCTURAL PATTERN OF CANCER IN RURAL POPULATION OF ARARAT VALLEY, ARMENIA E. Matevosyan, MPH student A.
Gastrointestinal system Part II The oesophagus. A muscular tube Conduction of food and drink Sphincters at top and bottom.
Slides last updated: March 2015 CRC: EPIDEMIOLOGY.
CLINICAL AND ENDOSCOPIC CORRELATION OF INFLAMMATORY BOWEL DISEASE Coordinator: Prof. Univ. Dr. Simona Băţagă Students: Andra Oltean Stoica Ioan Adrian.
Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Colorectal Cancer - UK December 2011 For more information.
XXI Congresso Nazionale SICOB - Cagliari Aprile 2013 ANALISI FATTORIALE DELL’OBESITÀ NELLA U.E.: SESSO, ETÀ, EDUCAZIONE Dott. Vincenzo Borrelli.
First Author: Radu Cristina Co-Authors: Stefan Anda Tripon Florin Crauciuc George Coordinators: Banescu Claudia, MD Demian Smaranda, MD The importance.
Dr Heather O Dickinson Department of Child Health University of Newcastle
JSNA 2012: Summary of Main Findings. Infant mortality trend, England, Yorkshire and Humber and North East Lincolnshire There have been big reductions.
MAJOR EVENTS AND EVOLUTION IN CYSTIC FIBROSIS PATIENTS Author: Alexandra Martin Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy Târgu-
Very low CHD mortality among men aged in several states in the United States Akira Sekikawa, MD, PhD, PhD Lewis H Kuller, MD, DrPH Department of.
Stomach – UK July 2007.
BREAST CANCER Breast cancer  Breast cancer is one of the commonest causes of death in many developed countries in middle-aged women, and is becoming.
© Cancer Research UK 2005 Registered charity number Oesophagus Cancer The statistics in this presentation are based on the Oesophagus CancerStats.
Slides last updated: March Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
Gastric Cancers in Texas: Are Nitrates the Problem?
SKIN CANCER PREVENTION May Skin Cancer in Saskatchewan & Canada PART TWO.
Seasoning with... CPPD, 5FU? Uhm... Chopped Chopped first or at the end? BBQed, Steamed or microwaved Then... cooked or..... Marinating? With Taxanes,
 Increase in adenocarcinomas and decreasing squamous cell histology  Squamous cell associated with tobacco, diet (nitrosamines) and alcohol.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
Epithelial Malignant Tumours of Maxillofacial Region Diagnostics Treatment and Complications. By: Dr Ahmeda Ali.
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
Gastrointestinal pathology esophagus and stomach lecture 2
By Caitlin Feeney January 5, 2010
Jun Li, MD MPH Epidemic Intelligence Service Officer
Gender difference in age, risk factors and histological characteristics of lung cancer patients, presented to the Respiratory Unit of Teaching Hospital.
Skin cancer at the National Dermatology Hospital from 2007 to 2010
Tuberculosis Associated with Human Immunodeficiency Virus Infection in Mures County, Romania ( ) Gabriela Jimborean1, Roxana Nemes2, Paraschiva.
Liver Cancer (C22): Percentage Distribution of Cases Diagnosed By Morphological Type, by Sex, UK Male Female Average Average Morphological Type.
Thyroid Cancer Survival – Population based study – EUROCARE-5
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
National Cancer Statistics in Korea, 2015
Authors: David Cunningham et al Date posted: April 3, 2008
Jianguang Ji, Kari Hemminki  Clinical Gastroenterology and Hepatology 
CUP Incidence UK, 2012 (C77-80) CUP has the 10th highest number of new cancer cases each year in the UK   England Wales Scotland N Ireland UK Male 3,730.
Cholangiocellular Carcinoma Interactive Case Discussion
Presentation transcript:

The evolution of esophageal cancer between in Mureș county Coordinator: Dr. Radu Florin Demian First author: Pál Hunor

Background – Worldwide and EU Worldwide (8th most common cancer) ,645 cases ,000 cases Rate of incidence - highest in South Africa ( ♂, ♀ ) -lowest in West of Africa ( ♂ ) and South Europe ( ♀ ). -83% in less developed regions of the world - 5 th most common cancer in men In the EU, 2008: - highest rates: UK, 14 ( ♂ ) and 5 ( ♀ )cases/100,000 pers. - lowest rates: Cyprus ( ♂ ) and Greece ( ♀ ) (1 case and less than 1 case/100,000 pers.)

Background – Romania (rate per 100,000 pers.) incidence 3 -mortality 1, incidence 2,32 -mortality 2, incidence 3,9 -mortality 3,5 Mureș county ( citizens) - lowest incidence in 2012, 0,3113% - highest incidence in 2013, 0,8751%

About Two major types - squamous cell carcinoma (SCC) - adenocarcinoma (AC) - < 1-2 % Sarcomas, small cell carcinomas and other types of cancer A. SCC - middle or upper 1/3 B. AC in the lower 1/3 or junction of the esophagus and stomach One of the least studied and deadliest cancers worldwide Extremely aggressive nature, poor survival rate.

Major aethiological factors Smoking Alcool consumption Malnutrition ( beta-carotene, B-vitamins, vitamin C and E, selenium) Barrett’s oesophagus

Aim, material and methods Follow the evolution of esophageal cancer in Mureș county between , by incidence, distribution by sexes, place of provenance, by group of ages, survivals and cytostatic threatment schemes. Retrospective study on 66 pacients (55 male, 11 female) - threated in the Oncology Clinics of Targu Mureș.

Distribution by sexes Distribution by sexes

Distribution by place of provenance

Distribution by group of ages

Survival curves

Cytostatic threatment  53 cycles, 11 schemes Cisplatin8 Carboplatin6 Gemcitabin7 Oxaliplatin2 5-FU3 Carboplatin + Docetaxel11 Carboplatin+ Paclitaxel7 Gemcitabin + Carboplatin4 Capecitabin + Cisplatin2 Epirubicin + Cisplatin2 Epirubicin ă + Oxaliplatin ă 1

Conclusions Low incidence More frequent at males More frequent at rural areas Most of cases are between ages (31/66), no cases below 40 Simultaneous decrease of the age group and increase of Two year survival is low Managing major risk factors (especially smoking and alcool consumption) should reduce the incidence, or at least prevent appearing at younger ages (41-50).

Thanks for the attention!